Cocrystal Pharma to Participate in a Fireside Chat at the Zacks SCR Life Sciences Virtual Investor Forum on March 13, 2025
Cocrystal Pharma (Nasdaq: COCP) has announced its participation in the Zacks SCR Life Sciences Virtual Investor Forum scheduled for March 13, 2025. The company's management will engage in a fireside chat at 11:30 a.m. Eastern time (8:30 a.m. Pacific time), hosted by Zacks Small Cap Research Senior Analyst David Bautz, PhD.
Investors can pre-register for the virtual presentation through Cocrystal's website and will have the opportunity to:
- Submit questions during the live event
- Request one-on-one meetings with management via the 'Book A Meeting' button
- Access a replay of the event through the company's website
Cocrystal Pharma (Nasdaq: COCP) ha annunciato la sua partecipazione al Zacks SCR Life Sciences Virtual Investor Forum programmato per il 13 marzo 2025. Il management dell'azienda parteciperà a una chiacchierata informale alle 11:30 ora orientale (8:30 ora del Pacifico), ospitata dall'analista senior di Zacks Small Cap Research, David Bautz, PhD.
Gli investitori possono pre-registrarsi per la presentazione virtuale attraverso il sito web di Cocrystal e avranno l'opportunità di:
- Inviare domande durante l'evento dal vivo
- Richiedere incontri one-to-one con il management tramite il pulsante 'Prenota un incontro'
- Accedere a una registrazione dell'evento attraverso il sito web dell'azienda
Cocrystal Pharma (Nasdaq: COCP) ha anunciado su participación en el Zacks SCR Life Sciences Virtual Investor Forum programado para el 13 de marzo de 2025. La dirección de la empresa participará en una charla informal a las 11:30 a.m. hora del Este (8:30 a.m. hora del Pacífico), presentada por David Bautz, PhD, analista senior de Zacks Small Cap Research.
Los inversores pueden preinscribirse para la presentación virtual a través del sitio web de Cocrystal y tendrán la oportunidad de:
- Enviar preguntas durante el evento en vivo
- Solicitar reuniones individuales con la dirección a través del botón 'Reservar una reunión'
- Acceder a una repetición del evento a través del sitio web de la empresa
Cocrystal Pharma (Nasdaq: COCP)는 Zacks SCR 생명과학 가상 투자 포럼에 참여한다고 발표했습니다. 이 포럼은 2025년 3월 13일에 예정되어 있습니다. 회사 경영진은 동부 표준시 기준 오전 11시 30분 (태평양 표준시 기준 오전 8시 30분)에 Zacks Small Cap Research의 수석 분석가인 David Bautz 박사와 함께 화상 대화에 참여할 것입니다.
투자자들은 Cocrystal의 웹사이트를 통해 가상 발표에 사전 등록할 수 있으며, 다음과 같은 기회를 가질 수 있습니다:
- 실시간 이벤트 중 질문 제출
- ‘미팅 예약’ 버튼을 통해 경영진과 일대일 미팅 요청
- 회사의 웹사이트를 통해 이벤트 재생 보기
Cocrystal Pharma (Nasdaq: COCP) a annoncé sa participation au Zacks SCR Life Sciences Virtual Investor Forum prévu pour le 13 mars 2025. La direction de l'entreprise participera à une discussion informelle à 11h30, heure de l'Est (8h30, heure du Pacifique), animée par David Bautz, PhD, analyste senior chez Zacks Small Cap Research.
Les investisseurs peuvent se préinscrire à la présentation virtuelle via le site web de Cocrystal et auront l'opportunité de:
- Soumettre des questions pendant l'événement en direct
- Demander des réunions individuelles avec la direction via le bouton 'Réserver une réunion'
- Accéder à un replay de l'événement via le site web de l'entreprise
Cocrystal Pharma (Nasdaq: COCP) hat seine Teilnahme am Zacks SCR Life Sciences Virtual Investor Forum bekannt gegeben, das für den 13. März 2025 geplant ist. Das Management des Unternehmens wird um 11:30 Uhr Eastern Time (8:30 Uhr Pacific Time) an einem informellen Gespräch teilnehmen, das von David Bautz, PhD, Senior Analyst bei Zacks Small Cap Research, moderiert wird.
Investoren können sich über die Website von Cocrystal im Voraus für die virtuelle Präsentation registrieren und haben die Möglichkeit:
- Fragen während der Live-Veranstaltung einzureichen
- Einzelgespräche mit dem Management über die Schaltfläche 'Meeting buchen' anzufordern
- Über die Website des Unternehmens auf eine Wiederholung der Veranstaltung zuzugreifen
- None.
- None.
BOTHELL, Wash., March 06, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that management will participate in a fireside chat at the Zacks SCR Life Sciences Virtual Investor Forum on Thursday, March 13, 2025 at 11:30 a.m. Eastern time (8:30 a.m. Pacific time). The fireside chat will be hosted by Zacks Small Cap Research Senior Analyst David Bautz, PhD.
Pre-register for Cocrystal’s virtual presentation is available on the Cocrystal website here. Investors will have the opportunity to submit questions online during the live event and can request a one-on-one meeting with management by selecting the “Book A Meeting” button on Cocrystal’s presentation page. A replay of the event will be available on the Cocrystal website here.
About Virtual Investor Conferences®
Virtual Investor Conferences is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. Learn more about the event at www.virtualinvestorconferences.com.
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.
Contact:
Alliance Advisors IR
Jody Cain
310-691-7100
jcain@allianceadvisors.com
# # #
FAQ
When is Cocrystal Pharma (COCP) presenting at the Zacks SCR Life Sciences Virtual Investor Forum?
How can investors participate in Cocrystal Pharma's (COCP) virtual presentation?
Who will host the fireside chat with Cocrystal Pharma (COCP)?
Will there be a replay available of Cocrystal Pharma's (COCP) presentation?
